MAVS and metabolic dysfunction-associated steatotic liver disease: O-GlcNAcylation of MAVS is crucial in mediating its different actions,11,14 and we have recently linked O-GlcNAcylation to MASLD development.34 We investigated whether this posttranslational modification modulates MAVS effects on inflammation and steatosis.